baber/WOPTO huggingface dataset:
Patent NZ-531433-A (NZ)
Title: Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
Inventor: ZIMMERMANN PETER JAN
IPC: A61K31/4375
Filed: 2002-07-31
Abstract: Disclosed are compounds of the formula (I), where R1 is hydrogen, 1-4C-alkyl, 3-7C-cycloalkyl, 3-7C-cycloalkyl-1-4C-alkyl, 1-4C-alkoxy, 1-4C-alkoxy-1-4C-alkyl, 1-4C-alkoxycarbonyl, 2-4C-alkenyl, 2-4C-alkynyl, fluoro-1-4C-alkyl or hydroxy-1-4C- alkyl, R2 is hydrogen, 1-4C-alkyl, 3-7C-cycloalkyl, 3-7C-cycloalkyl-1-4C-alkyl, 1-4C-alkoxycarbonyl, hydroxy-1-4C-alkyl, halogen, 2-4C-alkenyl, 2-4C-alkynyl, fluoro-1-4C-alkyl or cyanomethyl, Arom is a R8-, R9-, R10- and R11-substituted mono- or bicyclic aromatic radical selected from the group consisting of phenyl, naphthyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-triazolyl, indolyl, benzimidazolyl, furanyl (furyl), benzofuranyl (benzofuryl), thiophenyl (thienyl), benzothiophenyl (benzothienyl), thiazolyl, isoxazolyl, pyridinyl, pyrimidinyl, quinolinyl and isoquinolinyl, X is oxygen or NH, or a salt thereof. Further disclosed are: the use of compounds of formula (I) in the preparation of a medicament for use in the treatment of gastrointestinal disorders; and a medicament comprising compounds of the formula (I).
Patent NZ-531521-A (NZ)
Title: Hydroxamic acid derivatives as MMP inhibitors
Inventor: DYKE HAZEL JOAN
IPC: A61P27/16
Filed: 2002-08-07
Abstract: A compound of formula (I) that are MMP inhibitors are disclosed wherein: R1 and R2, which may be the same or different, is each a hydrogen atom or a CF3, CF2H or CFH2 group, provided that when one of R1 or R2 is a hydrogen atom the other is a CF3, CF2H or CFH2 group; and the salts, solvates or hydrates thereof. The compounds are potent MMP inhibitors that do not cause tendonitis in a relevant animal model. The compounds may be expected to be of use in medicine, especially where the avoidance of side effects such as joint pain is desired.
Patent NZ-533455-A (NZ)
Title: Device for conditioning water produced by air conditioning or environmental dehumidification apparatuses or plants
Inventor: AKKAD OSMAN
IPC: C02F1/50
Filed: 2002-12-12
Abstract: Device for conditioning water produced by environmental conditioning or dehumidification apparatuses or plants, comprising a device ( 2 ) for measuring the quantity of water produced by a condenser ( 1 ) which transforms atmospheric humidity into water, a feeder ( 4 ) of a corrective composition of salts and mineral substances, preferably in the form of tablets (P), for dispensing at least one of them in proportion to the quantity of water measured, a mixing vessel ( 5 ) receiving the measured water and at least a tablet (P) provided by the feeder ( 4 ), a control and command unit ( 6 ) that activates the feeder ( 4 ) in proportion to the quantity of water measured and received, and a tank ( 7 ) for collecting and filtering the water provided with means ( 70 ) for filtering micro-organisms and bacteria and a valve ( 81 ) for the exit of potable water.
Patent NZ-534719-A (NZ)
Title: Conjugates of therapeutic or cytotoxic agents and biologically active peptides
Inventor: FUSELIER JOSEPH A
IPC: A61K47/48
Filed: 2003-03-03
Abstract: Disclosed are conjugates of therapeutic or cytotoxic agents and biologically active peptides and methods of use thereof.
Patent NZ-538888-A (NZ)
Title: Rope for heavy lifting applications
Inventor: KNUDSEN ROBERT B
IPC: D04C1/12
Filed: 2003-10-07
Abstract: A large diameter rope having improved fatigue life on a sheave, pulley, or drum is disclosed. This rope includes a blend of HMPE filaments and liquid crystal polymer filaments selected from the group of lyotropic polymer filaments and thermotropic polymer filaments. The rope may be constructed as a braided rope, a wire-lay rope, or a parallel core rope.
Patent NZ-539754-A (NZ)
Title: Tamper proof and tamper evident cap for aerosol can
Inventor: BLOOMFIELD JOHN IAN
Filed: 2005-05-02
Abstract: A tamper evident cap for an aerosol can has a pair of concentric can engagement "rings" 9 and 10, ring 9 on the distal base end of the cap and ring 10 on the top end of the cap. The distal portion and the top portion are joined by a frangible portion 5. The cap is fitted to the top of the can with both of the rings engaging respective formations on the can. When the top end of the cap is removed from the base portion by breaking the frangible portion 5, the base portion remains attached to the can by engagement of the ring 9 and the top portion may be refitted to the can using the ring 10 of the top portion. Fig. 7 shows a variation of the arrangement.
Patent NZ-543348-A (NZ)
Title: Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
Inventor: CARDINEAU GUY A
IPC: C12N15/82
Filed: 2004-05-04
Abstract: Disclosed is a recombinant expression vector for expressing an immunoprotective antigen in a plant, comprising a DNA sequence encoding the hemagglutinin antigen of Avian Influenza Virus, wherein the vector is pCHA. In particular expression of the antigen is in the fruit of the plant, particularly a tomato plant.
Patent NZ-544158-A (NZ)
Title: Amino acid composition and fluid replacement
Inventor: ABE TAKASHI
IPC: A23L1/305
Filed: 2004-05-31
Abstract: Use of an amino acid composition in the manufacture of a supplementary liquid for promoting a process wherein body fats are converted into energy required for physical exercise during and/or after anoxic or anaerobic motions performed under an extremely high load, wherein said amino acid composition comprises the following amino acids in the molar ratios specified below: not more than 12 moles of alanine, not more than 5 moles of arginine, not more than one mole of aspartic acid, not more than 4 moles of glutamic acid, 7 to 20 moles of leucine, 5 to 11 moles of lysine, not more than 5 moles of methionine, 0.5 to 5 moles of phenylalanine, 4 to 30 moles of proline, not more than 5 moles of serine, 2 to 15 moles of threonine, not more than 5 moles of tryptophan, 1 to 9 moles of tyrosine, 4 to 8 moles of valine, and 0.01 to 20 moles of glutamine.
Patent NZ-550761-A (NZ)
Title: Automatic changeover pressure regulator, to allow for connection to reserve container while main container can be refilled
Inventor: OLD CHARLES M
Filed: 2003-12-09
Abstract: A pressure regulator (10) includes a changeover regulator (12) with plural inlets (not shown in this view). Inside the regulator, each inlet has a closure member (62) connected to a diaphragm (100) for control of the closure members (62) in response to pressure inside the regulator (12). Biasing members (56) are stabilized in position by either an apertured plate (102), a cup (104) or both. A changeover handle (19) depresses one spring (56) or the other to bias one closure member (62) open to admit gas from the associated inlet.
Patent NZ-553536-A (NZ)
Title: RFID system performance monitoring
Inventor: SULLIVAN MICHAEL S
Filed: 2005-08-16
Abstract: A system for monitoring the performance of a radio frequency identification (RFID) system operating to track the movement of articles through a supply chain is disclosed. The system comprises first database; and, a processor operably coupled to a program storage device to receive instructions stored in the program storage device. When the processor executes the received instructions, the processor performs the following operations: receive first information that identifies each individual RFID tag being used in the RFID system; receive second information generated by RFID readers and comprising the results of one or more attempts to read RFID tags as they pass by reader stations at one or more points in the supply chain; associate at least some of the second information with the first information; and, compile the first and second information and their associations into the first database. An individual article moving through the supply chain may be tracked by its association with the received first information of an RFID tag that is encoded with the received first information and attached to the article.
Patent NZ-562893-A (NZ)
Title: An aqueous dispersion and its use for the anti-mould treatment of rinded cheeses
Inventor: CAPRA VITTORIO
Filed: 2007-10-26
Abstract: Disclosed is an aqueous dispersion comprising, with reference to 100 parts of water: from 1 to 150 parts of a polymer the monomeric units of which are selected from the group consisting of ethylene, vinyl and acrylic esters of saturated fatty acids having from 2 to 16 carbon atoms, vinyl versatate, and maleic and formic acid esters of saturated alcohols having from 4 to 8 carbon atoms, and from 0.01 to 5 parts of an ion-exchange zeolite containing silver and/or copper ions; when used to treat rinded cheeses. Further disclosed is a process for the treatment of a rinded cheese and its subsequent product, said process comprising a step consisting of the formation of a film coating of the cheese with the use of the dispersion described.
Patent NZ-570642-A (NZ)
Title: Collagenase for treating cellulite
Inventor: BADALEMENTE MARIE A
IPC: A61K8/66
Filed: 2007-02-22
Abstract: Disclosed is the use of purified collagenase for the manufacture of a medicament for the treatment of cellulite in a subject in need of such treatment, wherein said medicament is formulated for administration to the collagenous septa network of cellulite by injection, and wherein the purified collagenase is formulated for administration alone.
Patent NZ-578672-A (NZ)
Title: Information-retrieval systems, methods, and software with concept-based searching and ranking
Inventor: CUSTIS TONYA
IPC: G06F17/30
Filed: 2007-12-27
Abstract: A system has a processor and a memory and further comprises a set of target documents; and means for searching and identifying by the processor one or more of the set of target documents as result documents based on identifying a set of at least one concept associated with a user query. The means for searching and identifying includes means for identifying by the processor a first set of documents based at least in part on a set of word co-occurrence probabilities, with the set of word co-occurrence probabilities derived from at least one corpus of documents related to the set of at least one concept. The means for searching and identifying one or more of the set of target documents further includes means for identifying one or more second documents based on inverse-document-frequency information as result documents and means for ranking the result documents based on the inverse-document-frequency information and the set of word co-occurrence probabilities and means for ranking the result documents based on importance of the set of at least one concept to each of the result documents determined based at least in part on the set of word co-occurrence probabilities. Also disclosed are related methods of processing a query and searching methods. A method and a system for using a query having one or more query terms to identify a set of one or more documents within a database are further disclosed. The system has a processor and a memory and further comprises a code set adapted to identify a set of at least one concept associated with one or more query terms comprising a query; determine for each of one or more documents in the database a score based on a) occurrence of one or more of the query terms in the document; and b) occurrence of one or more non-query terms in the document and display one or more of the documents within a search result based on its determined score. The non-query terms is known to co-occur with one or more of the query terms in a set of documents and being associated with the set of at least one concept.
Patent NZ-580279-A (NZ)
Title: Aerosolised flu antibodies derived from annimal colostrum products.
Inventor: RAWLIN GRANT THOMAS
IPC: A61P31/16
Filed: 2008-04-11
Abstract: Disclosed is a use of an antibody derived from animal colostrum products for treatment or prophylaxis of influenza infection. A antigen selected from the group consisting of H1, H3 and H5 said immune material being derived from hyperimmune milk products such as hyperimmune colostrum said hyperimmune milk products being prepared by inoculation of mammals with antigen comprising a least one Influenza A antigen selected from the group consisting of H1, H3 and H5.
Patent NZ-580630-A (NZ)
Title: Cigarette paper with banded calcium carbonate regions
Inventor: LI PING
IPC: A24D1/02
Filed: 2008-06-27
Abstract: A smoking article which includes a quantity of tobacco and a wrapper paper surrounding the quantity of tobacco and defining a tobacco rod. The wrapper paper has a transverse direction and includes at least one banded region between ends of the tobacco rod. The banded region has at least two layers. A first layer which includes a mixture of starch material and calcium carbonate particles. The content of calcium carbonate particles in the first layer is at least about 80% of the content of the starch material in the first layer. A second layer which includes a starch material. The first layer is on the wrapper paper and the second layer is on the first layer. The calcium carbonate content of each banded region is greater than about 35% by weight of the starch content of each band.
Patent NZ-582035-A (NZ)
Title: Di-substituted amides for enhancing glutamatergic synaptic responses
Inventor: LEE STEPHEN
IPC: A61K31/41
Filed: 2008-05-16
Abstract: Disclosed are di-substituted amide compounds of formula I, wherein the substituents are as described within the specification. Examples of compounds of formula I include: N-Cyclohexyl-N-methyl-[2,1,3]-benzoxadiazole-5-carboxamide; and trans-4-[(2,1,3-Benzoxadiazol-5-ylcarbonyl)(methyl)amino]cyclohexyl N,N-dimethyl glycinate hydrochloride. Further disclosed is a pharmaceutical composition comprising an effective amount of a compound of formula I, and the use of a compound of formula I in the manufacture of a medicament for use in the treatment of a glutamatergic condition, memory or other cognitive impairments, schizophrenia, Parkinson's disease, ADHD, Rett Syndrome, respiratory depression, breathing-related sleep disorders or sleep apnea, Fragile-X Syndrome, Alzheimer's disease.
Patent NZ-584250-A (NZ)
Title: Method for compressing gaseous fuel for fuelling vehicle and device for implementation thereof
Inventor: SAFRONOVS ALEKSEJS
IPC: F04B9/125
Filed: 2008-09-09
Abstract: A preparation of gaseous fuel (natural gas for example) for its further transfer under pressure to fuel tank of a vehicle (22). This is achieved by a method for compressing gas (29) by alternate transfer of gas into two vertically arranged compressing vessels (1, 2). Gas is compressed and forced into high-pressure vessels by alternately filling the compressing vessels with working fluid (30) under pressure by means of a hydraulic drive (5). Each cycle of compressing gas and forcing it out of the compressing vessels is performed until the respective vessel is fully filled with the working fluid. The working fluid is alternately forced out of one compressing vessel into the other in response to a signal sent by a fluid-level sensor (4).
Patent NZ-591027-A (NZ)
Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
Inventor: MASCITTI VINCENT
IPC: A61K31/357
Filed: 2009-08-17
Abstract: Disclosed are dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives of Formula (A) or (B), crystal structures and pharmaceutical compositions thereof, and methods for their preparation. Specific examples of the compounds of Formula A and B include: (1S,2S,3S,4R,5S)-1-hydroxymethyl-5-[3-(4-methoxy-benzyl)-4-methyl-phenyl]-6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol, 2-(4-ethoxybenzyl)-4-((1S,2S,3S,4R,5S)-2,3,4-trihydroxy-1-(hydroxymethyl)-6,8-dioxa-bicyclo[3,2,1]oct-5-yl)benzonitrile, and (1S,2S,3S,4R,5S)-5-{ 4-chloro-3-[4-(oxetan-3-yloxy)-benzyl]-phenyl} -1-hydroxymethyl-6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol. Compounds of Formula (A) and (B) are sodium-glucose co-transporter (SGLT) inhibitors and are useful for treating obesity and obesity-related disorders, Type 2 diabetes and diabetes related disorders.
Patent NZ-591817-A (NZ)
Title: Live trap for trapping rodents with two interchangeable trap mechanisms
Inventor: BERGER JONATHAN D
IPC: A01M23/08
Filed: 2009-09-21
Abstract: A live trap 100 for trapping rodents, comprises a housing having an interior space, a bottom having an inner surface at least in part defining the interior space, and at least one entry opening 106 through which rodents enter the interior space of the housing, at least one trap mechanism disposed within the interior space of the housing to inhibit rodents that enter the housing from exiting the housing, and a bridge assembly 121 positioned within the interior space of the housing. The bridge assembly 121 includes a platform spaced above the inner surface of the bottom of the housing and configured to support the at least one trap mechanism above the inner surface of the bottom of the housing. The bridge assembly 121 extends above less than the entire inner surface of the bottom of the housing to permit rodents exiting the trap mechanism to step down from either the bridge assembly 121 or the at least one trap mechanism onto the inner surface of the bottom of the housing. The at least one trap mechanism is releasably mounted on the bridge assembly 121.
Patent NZ-591991-A (NZ)
Title: Methods and compositions for fining beverages comprising the addition of 10-300ppm pectin
Inventor: DUAN WEIDONG
IPC: A23L29/20
Filed: 2005-09-20
Abstract: Disclosed is the use of a composition comprising pectin as a finings agent for beer, in which the effective amount of pectin is in the range of 10 to 80 ppm inclusive of the total beer volume, and in which the composition does not comprise isinglass. Further disclosed is a method of fining beer comprising adding to the beer a composition comprising pectin, in which the amount of pectin is in the range of 10 to 80 ppm inclusive of the total beer volume, and in which the composition does not comprise isinglass.
Patent NZ-595452-A (NZ)
Title: Board, panel or slab formed by stone agglomerate containing an organic binder of vegetable origin
Inventor: RAMON MORENO JOSE LUIS
IPC: C04B26/18
Filed: 2009-03-18
Abstract: PANEL OR SLAB FORMED BY STONE AGGLOMERATE CONTAINING AN ORGANIC BINDER OF VEGETABLE ORIGIN The disclosure relates to boards or slabs formed by stone agglomerate, the production of which comprises the use of an organic binder containing an ingredient of vegetable origin. Such boards or slabs are formed from granulated stone materials or similar which are subsequently agglomerated by means of a binder, specifically an organic resin containing one or more polyols of vegetable origin. Furthermore, through the use of the binder together with materials originating from waste and used and/or recycled products it is possible to obtain a high-performance material having a very high content of recycled or renewable-source material. The resulting board or slab containing in part a resin of vegetable origin is particularly suitable for use indoors, such as for kitchen or bathroom tops or any work surface, as well as for use as flooring or panelling.
Patent NZ-596528-A (NZ)
Title: Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
Inventor: KISHI YASUHIRO
IPC: C12N15/09
Filed: 2010-04-22
Abstract: Patent No. 596528 Disclosed is a probe set to be used for identifying by fluorescent real-time PCR the type of the nucleotide at a mutation site of NS3 protease of HCV, said probe set comprising: a detection probe composed of an oligonucleotide having: a nucleotide sequence comprising said mutation site in said target nucleic acid, said mutation site comprising a nucleotide of interest; or a nucleotide sequence complementary to said nucleotide sequence; said oligonucleotide having a fluorescent substance attached to the 5’-end and a quencher attached to the 3’-end; and a counter probe composed of an oligonucleotide having: a nucleotide sequence comprising said mutation site, said mutation site comprising a nucleotide different from said nucleotide of interest; or a nucleotide sequence complementary to said nucleotide sequence, and wherein said detection probe has a modification introduced such that the melting temperature thereof is not less than 3°C higher than the melting temperature of the counter probe, and wherein the detection probe and counter probe are selected from the group consisting of gcatcttccgggctgc, ggcatcttccgggttg, ggcatcttccggtttgc, ggcatcttccggactgc, ggcatcttccggtctgc, tccgggctgctgtat, tcggggctgctgtatg, tcctggctgctgtgtg, tcaaggctgctgtatgca, tccgggttgctatatgca, tccggactgctatatgca, cgtgtgttggactgtct, gtgtgttgggctgtct, cgtgtgttggtctgtct, ccaggcctgtctcctac, ccaggcctatctcctac, ccaggccctctcctac, tccgggttgctgtgt, tccggtttgctgtatgca, tccggactgctgtgtg, tccggtatgctgtatgca
Patent NZ-610018-A (NZ)
Title: Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Inventor: SCOTT WILLIAM JOHNSTON
IPC: C07D487/04
Filed: 2011-11-08
Abstract: The disclosure relates to a family of 2,3-dihydroimidazo[1,2-c]quinazoline compounds as shown in Figure (I), or their stereoisomers, tautomers, N-oxides, hydrates, solvates or salts thereof. R1, R2, R3 are as disclosed in the specification. The disclosure also relates to pharmaceutical compositions containing these compounds and the use of these compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with PI3K activity. This includes treating hyper-proliferative and/or angiogenesis disorders, uncontrolled cell growth, inappropriate immune response and tumours. Example compounds include: 2-amino-N-(8-{ [(2 R)-2-hydroxy-3-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propyl]oxy} -7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide dihydrochloride 2-amino-N-{ 8-[2-hydroxy-3-(morpholin-4-yl)propoxy]-7-methoxy-2,3-dihydroimidazo[1,2- c]quinazolin-5-yl} pyrimidine-5-carboxamide N-(8-{ [(2R)-2-hydroxy-3-(pyrrolidin-1-yl)propyl]oxy} -7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide 2-amino-N-(8-{ [(2R)-2-hydroxy-3-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)propyl]oxy} -7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide dihydrochloride N-(8-{ [(2R)-3-(azetidin-1-yl)-2-hydroxypropyl]oxy} -7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyridine-3-carboxamide N-[8-({ (2R)-3-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-hydroxypropyl} oxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyridine-3-carboxamide
Patent NZ-611380-A (NZ)
Title: Steam characteristics automatic measuring device and geothermal power generating device
Inventor: MYOUGAN ICHIRO
IPC: G01N33/18
Filed: 2009-10-02
Abstract: 611380 Disclosed is an automatic steam characteristics-measuring device. The device includes an automatic non-condensable gas flowmeter (39) for automatically and continuously measuring a first flow rate of first non-condensable gas separated from steam taken out from under the ground by cooling the steam. The steam is divided into the first non-condensable gas and a condensate by the cooling. The device also includes a thermometer for measuring the temperature of the condensate. The device fruther includes a processor (29) for calculating a second flow rate of a second non-condensable gas dissolved in the condensate. The processor (29) calculates a total flow rate of the first non-condensable gas and the second non-condensable gas by adding the second flow rate to the first flow rate.